|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||||
| Cash | |||||||||||
| Inventory | |||||||||||
| Prepaid expenses | |||||||||||
| Deferred offering cost | |||||||||||
| Note receivable from sale of subsidiary | |||||||||||
| Assets from discontinued operations | |||||||||||
| Note receivable | |||||||||||
| Total Current Assets | |||||||||||
| Other investment | |||||||||||
| Intangible assets, net of accumulated | |||||||||||
| Total Assets | |||||||||||
| Accounts payable and accrued liabilities | |||||||||||
| Notes payable | |||||||||||
| Related Party | |||||||||||
| Total notes payable | |||||||||||
| Bank overdraft | |||||||||||
| Accounts payable and accrued liabilities | |||||||||||
| Accounts payable and accrued expenses – related party | |||||||||||
| Convertible notes payable, net | |||||||||||
| Advance from investor | |||||||||||
| Due to related party | |||||||||||
| Related Party | |||||||||||
| Total due to related party | |||||||||||
| Warrant liability | |||||||||||
| Derivative liability | |||||||||||
| Total Current Liabilities | |||||||||||
| Total Liabilities | |||||||||||
| Stockholders’ Deficit | |||||||||||
| Preferred stock: 7,000,000 authorized; $0.001 par value, 7,000,000 shares issued and outstanding | |||||||||||
| Common stock: 1,250,000,000 authorized; $0.001 par value, 167,166,897 and 162,569,807 shares issued and outstanding, respectively | |||||||||||
| Common Stock Issuable | |||||||||||
| Common Stock Returnable | |||||||||||
| Total common stock: 1,250,000,000 authorized; $0.001 par value, 167,166,897 and 162,569,807 shares issued and outstanding, respectively | |||||||||||
| Common stock issuable | |||||||||||
| Additional paid in capital | |||||||||||
| Accumulated deficit | |||||||||||
| Common Stock Issuable | |||||||||||
| Total Stockholders’ Deficit | |||||||||||
| Total Liabilities and Stockholders’ Deficit |
Loading...
